01:59 PM EDT, 06/24/2025 (MT Newswires) -- Health care stocks rose Tuesday afternoon with the NYSE Health Care Index adding 0.7% and the Health Care Select Sector SPDR Fund (XLV) gaining 1%.

The iShares Biotechnology ETF (IBB) climbed 2%.

In sector news, CVS Health (CVS), UnitedHealth (UNH) and Cigna (CI) must consider eliminating drug rebates before the government moves to change the system, Medicare and Medicaid chief Mehmet Oz said, according to a Bloomberg report.

In corporate news, Novo Nordisk ( NVO ) shares rose 1.2%. The company's weight loss drug Wegovy is now available in India.

Nektar Therapeutics ( NKTR ) shares more than doubled after the company's phase 2b trial of rezpegaldesleukin met its primary endpoint in people with atopic dermatitis.

Amarin ( AMRN ) shares jumped 34% after the company signed an exclusive license and supply agreement with Recordati to commercialize Vazkepa in 59 countries with a focus on Europe.

Hoth Therapeutics ( HOTH ) shares added 4.9% after the company's investigational candidate HT-001 met key efficacy goals in all patients in a phase 2a trial targeting skin toxicities caused by epidermal growth factor receptor inhibitors.